A Comparative Analysis of Efficacy of Rituximab in Patients with Primary Membranous Nephropathy

被引：0
|
作者：
Zhang Qianwei [1 ]
Xie Liyi [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024g2wf30dz
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO591
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Rituximab for idiopathic membranous nephropathy
    Remuzzi, G
    Chiurchiu, C
    Abbate, M
    Brusegan, V
    Bontempelli, M
    Ruggenenti, P
    LANCET, 2002, 360 (9337): : 923 - 924
  • [32] Response to 'rituximab in membranous nephropathy'
    Fervenza, Fernando C.
    Cosio, Fernando G.
    Erickson, Stephen B.
    Specks, Ulrich
    Herzenberg, Andrew M.
    Dillon, John J.
    Leung, Nelson
    Cohen, Irvin M.
    Wochos, Daniel N.
    Bergstralh, Eric
    Hladunewich, Michelle
    Cattran, Daniel C.
    KIDNEY INTERNATIONAL, 2008, 74 (03) : 392 - 392
  • [33] Efficacy of continues low dose rituximab in PLA2R-associated primary membranous nephropathy
    Cui, Zhuan
    Wang, Song
    Wanf, Yue
    Zheng, Danxia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2090 - I2091
  • [34] Efficacy of continues low dose rituximab in PLA2R-associated primary membranous nephropathy
    Cui, Zhuan
    Wang, Song
    Wanf, Yue
    Zheng, Danxia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [35] Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Membranous Nephropathy
    Podesta, Manuel A.
    Portalupi, Valentina
    Gennarini, Alessia
    Villa, Alessandro
    Rubis, Nadia
    Remuzzi, Giuseppe
    Ruggenenti, Piero L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 183 - 183
  • [36] Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies
    Ou, Jun-Yong
    Chen, Yuan-Wei
    Li, Tian-Long
    Shan, Hui-Zhi
    Cui, Sini
    Lai, Jun-Ju
    Xiao, Yun
    NEPHROLOGIE & THERAPEUTIQUE, 2022, 18 (02): : 104 - 112
  • [37] Belimumab and Rituximab for the Treatment of Primary Membranous Nephropathy: Initial REBOOT Results
    Nachman, Patrick H.
    Stelzig, Lia
    Sherman, Matthew A.
    Barry, William T.
    Chung, Sharon
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [38] Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?
    Cravedi, Paolo
    Remuzzi, Giuseppe
    Ruggenenti, Piero
    NEPHRON CLINICAL PRACTICE, 2014, 128 (3-4): : 261 - 269
  • [39] Treatment with rituximab in idiopathic membranous nephropathy
    Fiorentino, Marco
    Tondolo, Francesco
    Bruno, Francesca
    Infante, Barbara
    Grandaliano, Giuseppe
    Gesualdo, Loreto
    Manno, Carlo
    CLINICAL KIDNEY JOURNAL, 2016, 9 (06) : 788 - 793
  • [40] Rituximab promising for idiopathic membranous nephropathy
    Helene Myrvang
    Nature Reviews Nephrology, 2012, 8 (10) : 556 - 556
12345